Urine Ion Profiling for COVID-19 Detection Amid Competing Ions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing COVID-19 detection methods face challenges in accurately distinguishing between asymptomatic and pre-symptomatic individuals due to the inability to selectively measure ions in the presence of competing ions, leading to less accurate detection and measurement, especially when relying on RNA, antigens, or antibodies.

Innovation Solution

The method involves measuring and quantifying changes in mineral and ionic levels in urine samples without the need for SARS-CoV-2 virus, antibodies, or viral material, using devices and test strips to detect COVID-19 infection by analyzing urine samples for ions such as potassium and sodium.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If RNA, antigens, or antibodies are used for COVID-19 detection, then detection can be performed, but accuracy in distinguishing asymptomatic and pre-symptomatic individuals deteriorates due to inability to selectively measure ions in presence of competing ions

Engineering Contradiction:
Improvedetection accuracyVSAvoiddifferentiation reliability
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The invention segments the detection approach by using multiple specific ion measurements (sodium, potassium, calcium, magnesium) rather than relying on a single biomarker. This segmentation allows for a more nuanced detection profile that can distinguish between asymptomatic and pre-symptomatic individuals through patterns of ion level changes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses ion level changes as intermediary markers that reflect physiological changes during COVID-19 infection. By measuring electrolyte levels in urine samples, the method detects indirect physiological responses to viral infection, which provides better differentiation capability compared to direct viral detection methods.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If standard ion detection methods are used, then ion measurement can be performed, but selectivity deteriorates due to presence of competing ions

Engineering Contradiction:
Improveion measurement accuracyVSAvoidion selectivity
Core Design Contradiction:
Measurement precisionVSDifficulty of detecting and measuring

Solution Approach 1:

The invention measures multiple ion parameters simultaneously (sodium, potassium, calcium, magnesium) and analyzes their relative changes and ratios. By examining patterns across multiple parameters rather than single ion concentrations, the method achieves selective detection despite the presence of competing ions in the urine sample.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The detection system performs multiple functions by simultaneously measuring different ion types and analyzing various aspects of ion level changes (absolute levels, ratios, temporal patterns). This multi-functional approach enables selective detection of COVID-19 related physiological changes while filtering out interference from competing ions.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12422397B1Methods and devices for COVID-19 testing using urine samples
Publication Date: 2025.09.23 CHUKWU UCHENNA
  • US12422397B1 patent drawing
  • US12422397B1 patent drawing
  • US12422397B1 patent drawing

AI summary

The present invention generally includes methods, devices and/or kits for the detection of a COVID-19 infection in an individual by measuring the level or concentration or one or more ions present in a urine sample that is substantially free of COVID-19 RNA, antibodies, or antigen material.